Acquired hemophilia a hemostatic treatment with recombinant porcine factor VIII

被引：0
|
作者：
Sobolewska, A. [2 ]
Urbanska, A. [2 ]
Bednarska, M. [2 ]
Zawadzka, I. [2 ]
Witkowski, M. [1 ]
机构：
[1] Copernicus Mem Hosp, Dept Gen Haematol, Lodz, Poland
[2] Med Lab Synevo Copernicus, Lodz, Poland
来源：
CLINICA CHIMICA ACTA | 2024年 / 558卷
关键词：
D O I：
10.1016/j.cca.2024.118418
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
P1400
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Use of recombinant porcine factor VIII in treatment of acquired hemophilia A in four patients
    Kaveney, A.
    Danish, M.
    Philipp, C.
    [J]. HAEMOPHILIA, 2019, 25 : 34 - 35
  • [2] Critical Bleeding in Acquired Hemophilia A: Bypassing Agents or Recombinant Porcine Factor VIII?
    Tiede, Andreas
    [J]. HAMOSTASEOLOGIE, 2021, 41 (04): : 240 - 245
  • [3] Efficacy and safety of recombinant porcine factor VIII in Japanese patients with acquired hemophilia A
    Seki, Yoshinobu
    Ogawa, Yoshiyuki
    Kikuchi, Takahide
    Sakaida, Emiko
    Mizuta, Yuki
    Kitagawa, Tadayuki
    Takemura, Kazuhiko
    Miyaguchi, Yasuo
    Nogami, Keiji
    Matsushita, Tadashi
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024, 120 (04) : 482 - 491
  • [4] Recombinant B domain deleted porcine factor VIII for the treatment of bleeding episodes in adults with acquired hemophilia A
    Gomperts, Edward
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2015, 8 (04) : 427 - 432
  • [5] USE OF PORCINE FACTOR-VIII IN THE TREATMENT OF PATIENTS WITH ACQUIRED HEMOPHILIA
    MORRISON, AE
    LUDLAM, CA
    KESSLER, C
    [J]. BLOOD, 1993, 81 (06) : 1513 - 1520
  • [6] Evaluating the financial impact of utilizing recombinant porcine factor VIII or recombinant FVIIa for patients with acquired hemophilia A
    Bullano, Michael
    Cool, Christina
    Schultz, Bob G.
    Durgapal, Sneha
    Sacks, Naomi
    Liu, Yanmei
    Kee, Rebecca
    Batt, Katharine
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2023, 23 (02) : 225 - 230
  • [7] Real-world use of recombinant porcine sequence factor VIII in the treatment of acquired hemophilia A: EU PASS
    Miesbach, Wolfgang
    Curry, Nicola
    Knoebl, Paul
    Percy, Charles
    Santoro, Rita
    Schmaier, Alvin H.
    Trautmann-Grill, Karolin
    Badejo, Kayode
    Chen, Jie
    Nouri, Masoud
    Oberai, Pooja
    Klamroth, Robert
    [J]. THERAPEUTIC ADVANCES IN HEMATOLOGY, 2024, 15
  • [8] TREATMENT OF ACQUIRED HEMOPHILIA WITH PORCINE FACTOR-VIII CONCENTRATE - LIGHTS AND SHADOWS
    MORFINI, M
    LONGO, G
    RAFANELLI, D
    ROSSI, G
    FRANCOIS, C
    FILIMBERTI, E
    CINOTTI, S
    [J]. BLOOD, 1993, 82 (10) : A597 - A597
  • [9] Recombinant porcine factor VIII in acquired hemophilia A: Experience from two patients and literature review
    Hayden, Alexander
    Candelario, Nellowe
    Moyer, Genevieve
    [J]. RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2022, 6 (02)
  • [10] Overview of the structure and manufacturing process for OBI-1, a recombinant porcine sequence, factor VIII for the treatment of acquired hemophilia A
    Wojciechowski, Peter
    Lai, Chee Kong
    Xiong, Yi
    Deer, Frank
    [J]. HAEMOPHILIA, 2014, 20 : 181 - 181
12345